Publication | Closed Access

A phase I–II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer

Poor Prognosis HeadMedicineFactor SupportPharmacologyPharmacotherapyHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyCancer ResearchPhase I–ii Study